Treatment outcomes with purine nucleoside analog alone or with rituximab for hairy cell leukemia at first relapse.
Hu R, Wei W, Mian A, Gonter-Aubin K, Kabel C, Mato A, Stephens DM, Hanlon A, Khajavian S, Shadman M, Brander D, Madanat Y, Park JH, Tallman M, Pinilla-Ibarz J, Hill BT.
Hu R, et al. Among authors: park jh.
Eur J Haematol. 2022 May;108(5):379-382. doi: 10.1111/ejh.13744. Epub 2022 Jan 27.
Eur J Haematol. 2022.
PMID: 35043475